Table 2.

Hazard Ratio (HR) (95% CIs) for mortality across groups of admission WBCc

WBCc	Non-adjusted		Model 1
	HR (95% CIs)	P value	HR (95% CIs)	P value
30-day mortality WBCc, K/uL
≤ 11 K/uL	1.0 (ref)	/	1.0 (ref)	/
> 11 K/uL	2.583 (1.361–4.905)	0.004	1.994 (1.058–3.76)	0.033
90-day mortality WBCc, K/uL
≤ 11 K/uL	1.0 (ref)	/	1.0 (ref)	/
> 11 K/uL	3.161 (1.756–5.693)	< 0.001	2.118(1.175–3.819)	0.013
1-year mortality WBCc, K/uL
≤ 11 K/uL	1.0 (ref)	/	1.0 (ref)	/
> 11 K/uL	2.741 (1.569–4.789)	< 0.001	2.37 (1.343–4.181)	0.003
5-year mortality WBCc, K/uL
≤ 11 K/uL	1.0 (ref)	/	1.0 (ref)	/
> 11 K/uL	2.090 (1.234–3.541)	0.006	1.499 (0.932–2.411)	0.095

Non-adjusted model adjusted to: none;

Adjusted model 1 adjusted to: age, hypertension, valvular disease, stroke, CHF, atrial fibrillation, renal disease, BUN, type of AAD and treatment type

HR: Hazard Ratio; WBCc: White blood cell count; CHF: congestive heart failure; BUN: blood urea nitrogen